Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix

J S Day1, M Ding, P Bednarz

  • 1Erasmus Orthopaedic Research Laboratory, Erasmus MC, University Medical Centre of Rotterdam, EE1614, P.O. Box 1738, DR, Rotterdam 3000, The Netherlands.

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|April 22, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAMKK2 is upregulated in primary human osteoarthritis and its inhibition protects against chondrocyte apoptosis.

Osteoarthritis and cartilage·2023
Same author

Bone quality in an ovariectomized monkey animal model treated with two doses of teriparatide for either 18 months, or 12 months followed by withdrawal for 6 months.

Bone·2022
Same author

Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis.

Osteoarthritis and cartilage·2021
Same author

Bacterial Streak and Bulb Rot of Sweet Onion: II. Epiphytic Survival of Pseudomonas viridiflava in Association with Multiple Weed Hosts.

Plant disease·2019
Same author

First Report of Downy Mildew (Caused by Peronospora destructor) of Onion in Georgia.

Plant disease·2019
Same author

First Report of Rhizoctonia solani AG-2-4 on Carrot in Georgia.

Plant disease·2019

Bisphosphonates improve bone strength in osteoporosis by increasing bone mass and altering structure, not by changing the calcified matrix itself. Microdamage accumulation may counteract matrix stiffening effects.

Area of Science:

  • Orthopedics
  • Biomaterials Science
  • Bone Physiology

Background:

  • Bisphosphonates are key osteoporosis treatments.
  • Their mechanism for reducing fracture risk is debated, focusing on bone mass, architecture, and mineralization.

Purpose of the Study:

  • To investigate bisphosphonate effects on canine trabecular bone architecture and matrix properties.
  • To differentiate contributions of bone mass, architecture, and mineralization to bone strength.

Main Methods:

  • Utilized micro-computed tomography, finite element modeling, and mechanical testing on canine vertebrae.
  • Analyzed calcified matrix and trabecular architecture independently.
  • Assessed histomorphometry and microdamage.

Main Results:

Related Experiment Videos

  • Bisphosphonate treatment increased apparent Young's modulus, decreased bone turnover, and increased matrix density and microdamage.
  • No change was observed in the calcified matrix's effective Young's modulus.
  • Increased bone strength was attributed to bone mass and architectural changes.

Conclusions:

  • Bisphosphonates enhance bone strength primarily through increased bone mass and improved trabecular architecture.
  • Microdamage accumulation may offset potential matrix stiffening from increased density.
  • Further research is needed to fully elucidate bisphosphonate effects on bone quality.